Enabling Consideration Of Packaging In The Early Stage Of Combination Product Development
By Liang Fang, Ranjana Singh, Cathy Zhao, West Pharmaceutical Services, Inc.
Since it is very costly to rework a drug formulation due to an incompatibility with its packaging, combination product regulation drives the early understanding of drug/container compatibility for the intended use. This poster provides two case studies to show how West assess drug/packaging interactions and demonstrates the importance and feasibility of taking the container system into consideration in the early drug development stage.
VIEW THE POSTER!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Pharmaceutical Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
West Pharmaceutical Services, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more